The Cutting Edge of Care for Barrett’s Esophagus
The Northwestern Medicine Comprehensive Program in Barrett’s Esophagus and Early Esophageal Cancer
Start your healing journey.
Schedule an appointment today with one of our esophageal specialists.
Lorem Ipsum
For patients who have risk factors for developing Barrett’s esophagus and early esophageal cancer (BE/EAC), Northwestern Medicine offers a dedicated high risk screening clinic and treatment program. Relying on gastroesophageal reflux disease (GERD) symptoms alone can miss a significant number of individuals at risk. Only around 5 percent of GERD sufferers ever develop Barrett’s esophagus. Moreover, approximately half the people diagnosed with Barrett’s ever complained of GERD symptoms at all. That’s why we look beyond the typical risk factors to get a much clearer assessment of an individual’s likelihood of developing the disorder.
Each patient seen in our center will have a personalized plan for reflux management, lifestyle changes, and endoscopic surveillance developed for them. Integral to this approach is the use of novel innovation in BE/EAC. Northwestern Medicine uses the latest in noninvasive tools for BE/EAC screening. The program also features state of the art tissue sampling tools such as the WATS-3D brush and innovation in risk stratification with TissueCypher® which ensures that patients at increased risk to develop EAC can be offered endoscopic eradication therapy.
Excellence from Diagnosis to Treatment
All Rights Reserved. ©2026 by Northwestern Medicine® and Northwestern Memorial HealthCare.
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University.
Northwestern Medicine® | 251 East Huron Street | Chicago, IL 60611 | nm.org
Northwestern Medicine offers world-class care in your neighborhood, including nationally and locally ranked hospitals.
Northwestern Memorial Hospital
Northwestern Medicine Central DuPage Hospital
Northwestern Medicine Lake Forest Hospital
Northwestern Medicine Delnor Hospital
Northwestern Medicine Kishwaukee Hospital
Northwestern Medicine Valley West Hospital
Northwestern Medicine Marianjoy Rehabilitation Hospital
Northwestern Medicine Huntley Hospital
Northwestern Medicine McHenry Hospital
Northwestern Medicine Woodstock Hospital
Northwestern Medicine Palos Hospital
Treatment Procedures
Program for Endoscopic Eradication Therapy for BE/EAC
We offer endoscopic eradication therapy (EET) to all patients with BE-related neoplasia. We can also provide the full spectrum of treatment options for BE, including:
- Endoscopic resection
- Radiofrequency ablation
- Cryotherapy
Minimally Invasive Surgery and Robotic Esophagectomy for EAC
The Northwestern Medicine PREMIER Program uses state-of-the-art robotic technology to perform an entire esophagectomy through five finger-tip-sized incisions in the abdomen and a small incision on the left side of the neck. This enables patients to start eating by mouth the day after surgery, eliminating the need for feeding tubes. Patients typically experience less pain and discomfort, and most are discharged within three to five days.
Laparoscopic and Endoscopic Treatments for GERD
We provide a multidisciplinary approach to GERD management that’s tailored to each patient, from standard PPI therapy to surgical anti-reflux options, to endoscopic anti-reflux procedures, such as transoral incisionless fundoplication.
Benefits of Research
Our program is part of the TREAT-BE Consortium, one of the largest research enterprises in the world focused on improving treatment of Barrett’s esophagus and early esophageal cancer. Our previously published data highlights that Northwestern Medicine outcomes rank as some of the highest in the world for complete eradication of this disease and the lowest rates of recurrence after endoscopic eradication therapy.
Northwestern Medicine offers world-class care in your neighborhood, including nationally and locally ranked hospitals.
Northwestern Memorial Hospital | Northwestern Medicine Central DuPage Hospital | Northwestern Medicine Lake Forest Hospital
Northwestern Medicine Delnor Hospital | Northwestern Medicine Kishwaukee Hospital | Northwestern Medicine Valley West Hospital
Northwestern Medicine Marianjoy Rehabilitation Hospital | Northwestern Medicine Huntley Hospital | Northwestern Medicine McHenry Hospital
Northwestern Medicine Woodstock Hospital | Northwestern Medicine Palos Hospital
Meet Our Barrett’s Esophagus Team
Srinadh Komanduri, MD
Program Director and Advanced Endoscopist (Gastroenterology)
John E. Pandolfino, MD
Chief, Division of Gastroenterology and Hepatology
Rachel L. Amdur, MD
Internal Medicine
Angelo Costas, MD
Internal Medicine
Dustin A. Carlson, MD
Esophagology
Domenico A. Farina, MD
Esophagology
Jeffrey S. Fronza, MD
Gastrointestinal Surgery
Bruce L. Henschen, MD
Internal Medicine
Peter J. Kahrilas, MD
Esophagology
Samuel S. Kim, MD
Thoracic Surgery
Amrita Sethi, MD
Gastroenterology
Katherine A. Hanley, PA-C
Gastroenterology
Whitney A. Kucher, PA-C
Gastroenterology
Bethany M. Doerfler, RD
Registered Dietitian
Screening and Surveillance
High-Risk Screening Clinic for BE/EAC
Northwestern Medicine offers a dedicated high-risk screening clinic for patients with risk factors for BE/EAC. This clinic looks beyond typical risk factors and uses the lates noninvasive screening modalities, such as EsoCheck™, EsoGuard™ and transnasal endoscopy, for early detection. These techniques can identify BE and early EAC without the need for sedated endoscopy. The clinic also uses GERD management programs, reflux physiologic testing, weight loss and smoking cessation strategies to help lessen an individual’s level of risk.
Innovation in BE Screening and Surveillance
From incorporation of catheter- or string-based screening tests and magnetic capsule endoscopy to in-office trans nasal endoscopy, we strive to use the latest noninvasive tools for BE/EAC screening. The program also features state-of-the-art tissue-sampling tools, such as the WATS3D Brush, and innovation in risk stratification with TissueCypher® to help ensure that patients at a higher risk of EAC can be offered endoscopic eradication therapy. These tools allow us to offer longer surveillance intervals to patients at lower risk.
Faisal Qayyum Khan, MD
Gastroenterology
In this episode of Better Edge podcast, Sri Komanduri, MD, discusses the latest advances in the screening and management of Barrett's esophagus and esophageal cancer. He highlights the significance of risk stratification to enhance patient outcomes and minimize the incidence of interval cancers. Additionally, Dr. Komanduri emphasizes the importance of improving patient access to care and the role of advocacy organizations in supporting both patients and clinicians.